Market Overview:
The global Voriconazole market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising incidence of fungal infections, increasing demand for novel antifungal drugs, and growing awareness about fungal infections. The global Voriconazole market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into injection voriconazole and voriconazole freeze-dried powder. The injection voriconazole segment is expected to grow at a higher CAGR during the forecast period owing to its high efficacy and safety profile. On the basis of application, the market is divided into hospital, clinic, and other segments. The hospital segment dominates this market due to rising incidence rates of fungal infections in hospitalized patients across all regions studied in this research study.
Product Definition:
Voriconazole is a triazole antifungal agent used in the treatment of serious fungal infections.
Injection Voriconazole:
Injection voriconazole is an injectable form of medication used to treat fungal infections. It works by killing the fungi that are causing the infection. Voriconazole is commonly prescribed for ringworm, athlete's foot, and jock itch but can be used for other types of fungal infections as well.
Voriconazole Freeze-dried Powder:
Voriconazole (VZ) is an antibiotic medication used to treat bacterial infections. It works by killing the bacteria that are inside the cells. The drug has a wide range of applications including skin, respiratory, and urinary tract infections; pneumonia; and meningitis.
Application Insights:
The other application segment includes the use of voriconazole in the treatment of fungal infections acquired through solid organ transplantation, diabetic foot ulcers and Crohn's disease. The hospital application segment dominated the global market with a share of over 60% in 2017. Voriconazole is used for various skin and systemic infections caused by fungi, such as onychomycosis, tinea corporis, candida species infection including oral candida syndrome and vulvovaginal candidiasis. It is also used to prevent fungal diseases that are acquired during medical procedures or through contact with contaminated surfaces.
Voriconazole injection was approved by U.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. High awareness levels regarding COVID-19 and strong commercial sales of voriconazole based drugs are some factors responsible for continued dominance of this region.
Asia Pacific is anticipated to be the fastest growing regional market over the forecast period owing to increasing number of COVID-19 positive cases in countries, such as India and China, which are also major manufacturing hubs for various pharmaceutical companies active in this space.
Growth Factors:
- Increasing incidence of fungal infections: The increasing incidence of fungal infections is one of the major growth drivers for the Voriconazole market. Voriconazole is a highly effective drug against a wide range of fungi and is approved for use in patients with life-threatening fungal infections.
- Rising demand for targeted therapies: The growing demand for targeted therapies is another key growth driver for the Voriconazole market. Voriconazole offers a high degree of specificity and efficacy against various types of fungi, making it an attractive treatment option for patients with serious or life-threatening fungal infections.
- Growing awareness about antifungal drugs: There has been a growing awareness about antifungal drugs in recent years, which has helped to drive the growth of the Voriconazole market. This increased awareness has led to an increase in the number of patients seeking treatment for serious or life-threatening fungal infections with voriconazole therapy.
Scope Of The Report
Report Attributes
Report Details
Report Title
Voriconazole Market Research Report
By Type
Injection Voriconazole, Voriconazole Freeze-dried Powder
By Application
Hospital, Clinic, Other
By Companies
Pfizer, Teva, GeneTech Pharm, Novartis, Mylan, Squibb, Sandoz, Daiichi Sankyo, GSK, Cilag AG, Macherey-Nagel GmbH, Abbott, Takeda, Sichuan Beauty Sport Huakang Pharmaceutical, Jincheng HEALTH Pharmaceutical, Ebang Pharmaceutical, Aditya Pharma, Taj Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
139
Number of Tables & Figures
98
Customization Available
Yes, the report can be customized as per your need.
Global Voriconazole Market Report Segments:
The global Voriconazole market is segmented on the basis of:
Types
Injection Voriconazole, Voriconazole Freeze-dried Powder
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Teva
- GeneTech Pharm
- Novartis
- Mylan
- Squibb
- Sandoz
- Daiichi Sankyo
- GSK
- Cilag AG
- Macherey-Nagel GmbH
- Abbott
- Takeda
- Sichuan Beauty Sport Huakang Pharmaceutical
- Jincheng HEALTH Pharmaceutical
- Ebang Pharmaceutical
- Aditya Pharma
- Taj Pharmaceuticals
Highlights of The Voriconazole Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Injection Voriconazole
- Voriconazole Freeze-dried Powder
- By Application:
- Hospital
- Clinic
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Voriconazole Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Voriconazole is an antifungal medication used to treat fungal infections. It works by stopping the growth of the fungus. Voriconazole is usually taken by mouth, but it can also be given as a injection into a vein or as an ointment on the skin.
Some of the major companies in the voriconazole market are Pfizer, Teva, GeneTech Pharm, Novartis, Mylan, Squibb, Sandoz, Daiichi Sankyo, GSK, Cilag AG, Macherey-Nagel GmbH, Abbott, Takeda, Sichuan Beauty Sport Huakang Pharmaceutical, Jincheng HEALTH Pharmaceutical, Ebang Pharmaceutical, Aditya Pharma, Taj Pharmaceuticals.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Voriconazole Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Voriconazole Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Voriconazole Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Voriconazole Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Voriconazole Market Size & Forecast, 2018-2028
4.5.1 Voriconazole Market Size and Y-o-Y Growth
4.5.2 Voriconazole Market Absolute $ Opportunity
Chapter 5 Global Voriconazole Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Voriconazole Market Size Forecast by Type
5.2.1 Injection Voriconazole
5.2.2 Voriconazole Freeze-dried Powder
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Voriconazole Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Voriconazole Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Voriconazole Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Voriconazole Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Voriconazole Analysis and Forecast
9.1 Introduction
9.2 North America Voriconazole Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Voriconazole Market Size Forecast by Type
9.6.1 Injection Voriconazole
9.6.2 Voriconazole Freeze-dried Powder
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Voriconazole Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Voriconazole Analysis and Forecast
10.1 Introduction
10.2 Europe Voriconazole Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Voriconazole Market Size Forecast by Type
10.6.1 Injection Voriconazole
10.6.2 Voriconazole Freeze-dried Powder
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Voriconazole Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Voriconazole Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Voriconazole Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Voriconazole Market Size Forecast by Type
11.6.1 Injection Voriconazole
11.6.2 Voriconazole Freeze-dried Powder
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Voriconazole Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Voriconazole Analysis and Forecast
12.1 Introduction
12.2 Latin America Voriconazole Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Voriconazole Market Size Forecast by Type
12.6.1 Injection Voriconazole
12.6.2 Voriconazole Freeze-dried Powder
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Voriconazole Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Voriconazole Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Voriconazole Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Voriconazole Market Size Forecast by Type
13.6.1 Injection Voriconazole
13.6.2 Voriconazole Freeze-dried Powder
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Voriconazole Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Voriconazole Market: Competitive Dashboard
14.2 Global Voriconazole Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 Teva
14.3.3 GeneTech Pharm
14.3.4 Novartis
14.3.5 Mylan
14.3.6 Squibb
14.3.7 Sandoz
14.3.8 Daiichi Sankyo
14.3.9 GSK
14.3.10 Cilag AG
14.3.11 Macherey-Nagel GmbH
14.3.12 Abbott
14.3.13 Takeda
14.3.14 Sichuan Beauty Sport Huakang Pharmaceutical
14.3.15 Jincheng HEALTH Pharmaceutical
14.3.16 Ebang Pharmaceutical
14.3.17 Aditya Pharma
14.3.18 Taj Pharmaceuticals
